Higher cancer incidences found in regions near refineries and plants that release benzene

July 29, 2013, Wiley

The incidence of a particular type of blood cancer is significantly higher in regions near facilities that release the chemical benzene into the environment. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. This and other studies like it will be critical to identifying and enacting public health policies to decrease or prevent cancer.

Non-Hodgkin has been on the rise over the past few decades as industrial production in the United States has expanded. Benzene is one chemical carcinogen linked to blood cancers. Working with Dr. Christopher Flowers and colleagues in the Lymphoma Program at Emory University in Atlanta, Catherine Bulka, MPH, used publicly available data from the Environmental Protection Agency and the US Census Bureau to analyse the geographic patterns of non-Hodgkin lymphoma cases in the state of Georgia between 1999 and 2008. This group examined the associations between new cases of lymphoma and the locations of facilities—such as petroleum refineries and manufacturing plants—that released benzene into the surrounding air or water.

The investigators found that the metro-Atlanta region, Augusta, and Savannah had the highest incidences of non-Hodgkin lymphoma even when controlling for population size as well as for age, sex, and race demographics of the local region. Also, the incidence of non-Hodgkin lymphoma was significantly greater than expected surrounding benzene release sites located in the metro-Atlanta area and surrounding one benzene release site in Savannah. For every mile the average distance to benzene release sites increased, there was a 0.31 percent decrease in the risk of non-Hodgkin lymphoma.

"Our study is the first to examine the relationship between passive benzene exposure and the incidence of non-Hodgkin lymphoma at the state population level," said Bulka. "Our findings are limited without similar studies to corroborate our results, but we hope that our research will inform readers of the potential risks of living near facilities that release carcinogens into the air, groundwater, or soil," she added.

Explore further: HIV-associated lymphoma survival has not improved during the antiretroviral therapy era

More information: CANCER; Published Online: July 29, 2013 DOI: 10.1002/cncr.28083

Related Stories

HIV-associated lymphoma survival has not improved during the antiretroviral therapy era

July 27, 2013
Stable survival rates were observed for HIV-associated lymphoma patients during the antiretroviral therapy (ART) era in the US, according to a new study published July 26 in the Journal of the National Cancer Institute.

Type 2 diabetes linked to increased blood cancer risk

June 5, 2012
Patients with type 2 diabetes have a 20 percent increased risk of developing blood cancers, such as non-Hodgkin lymphoma, leukemia and myeloma, according to a new meta-analysis led by researchers at The Miriam Hospital. The ...

TCE exposure linked to increased risk of some cancers

May 30, 2013
Trichloroethylene (TCE) exposure has possible links to increased liver cancer risk, and the relationship between TCE exposure and risks of cancers of low incidence and those with confounding by lifestyle and other factors ...

Non-Hodgkin lymphoma survival doubles since early 1970s

May 23, 2013
More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report1 from Cancer Research UK.

Blood levels of immune protein predict risk in Hodgkin disease

December 10, 2012
Blood levels of an immunity-related protein, galectin-1, in patients with newly diagnosed Hodgkin lymphoma reflected the extent of their cancer and correlated with other predictors of outcome, scientists reported at the American ...

Recommended for you

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.